Astrana Health (NASDAQ:ASTH) Announces Quarterly Earnings Results

Astrana Health (NASDAQ:ASTH) announced its quarterly earnings results on Tuesday. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01), Briefing.com reports. The firm had revenue of $404.36 million during the quarter, compared to analysts’ expectations of $413.84 million. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The company’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.42 EPS. Astrana Health updated its FY24 guidance to $1.28 to $1.52 EPS.

Astrana Health Price Performance

ASTH stock traded up $0.11 during midday trading on Thursday, hitting $38.20. The stock had a trading volume of 5,009 shares, compared to its average volume of 152,369. Astrana Health has a 12-month low of $28.86 and a 12-month high of $45.71. The company has a market cap of $2.14 billion, a price-to-earnings ratio of 28.86, a PEG ratio of 1.20 and a beta of 1.12. The business has a 50-day moving average price of $40.24. The company has a current ratio of 2.11, a quick ratio of 2.11 and a debt-to-equity ratio of 0.42.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Jefferies Financial Group initiated coverage on shares of Astrana Health in a report on Monday, February 26th. They issued a “buy” rating and a $50.00 price target on the stock. Stifel Nicolaus lowered their target price on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Truist Financial boosted their price target on Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a report on Friday, March 1st.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.